Lansoprazole Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

AZD4635 Relative Bioavailability Study
Condition:   Healthy Volunteers Interventions:   Drug: AZD4635 50 mg nano-suspension (reference);   Drug: AZD4635 solid oral formulation - fasted;   Drug: AZD4635 solid oral formulation - fed;   Drug: Lansoprazole and AZD4635 50 mg solid oral formulation;   Drug: AZD4635 solid oral formulation variant 1 - fasted;   Drug: AZD4635 solid oral formulation variant 2 - fasted;   Drug: [14C] AZD4635 IV microtracer - fasted Sponsors:   AstraZeneca;   Quotient Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer
Condition:   Active Peptic Ulcer Disease/GI Bleeding Interventions:   Drug: Misoprostol+Lansoprazole;   Drug: Placebo +Lansoprazole Sponsor:   Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2018 Category: Research Source Type: clinical trials